This makes them very attractive on a long-term basis. These stocks are almost impossible to buy in size except during periods of market weakness, so you need to have your ducks lined up beforehand. When the time comes to buy Intel, you won't want to. The energy sector is making some sort of top here. This is traditionally the most laggard sector in the market.
Discretion thus remains the better part of valor here.
On the positive side of the ledger, meanwhile, most drug stocks and many big consumer growth stocks staged bear markets from 1998 or early 1999 until last spring, when they bottomed and embarked on new bull markets. This makes them very attractive on a long-term basis, and we thus consider any reactions in them as buying opportunities. This thus looks like a good time to identify your favorite stocks in each group, just in case a buying opportunity does present itself in late October. At this point, though, we suspect that we will be putting it back in the market sometime during the next month or two. Charts of the four best and worst-performing groups during the last seven weeks may be found, as usual, in the back of the report.